4(5)-2-(2,6-dimethylphenyl)ethylimidazole has been researched along with prazosin in 2 studies
| Studies (4(5)-2-(2,6-dimethylphenyl)ethylimidazole) | Trials (4(5)-2-(2,6-dimethylphenyl)ethylimidazole) | Recent Studies (post-2010) (4(5)-2-(2,6-dimethylphenyl)ethylimidazole) | Studies (prazosin) | Trials (prazosin) | Recent Studies (post-2010) (prazosin) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 7,914 | 713 | 682 |
| Protein | Taxonomy | 4(5)-2-(2,6-dimethylphenyl)ethylimidazole (IC50) | prazosin (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 5.87 | |
| Interstitial collagenase | Homo sapiens (human) | 4.036 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.638 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 6.963 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 0.0078 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.29 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.647 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0007 | |
| Bromodomain-containing protein 2 | Homo sapiens (human) | 0.0009 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0006 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0006 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 4.118 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | 9.9 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.5849 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 1.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kärki, NT; Puurunen, J; Ruskoaho, H; Savola, JM | 1 |
| Kaipiainen, S; Kärki, N; Puurunen, J; Ruskoaho, H; Savola, JM | 1 |
2 other study(ies) available for 4(5)-2-(2,6-dimethylphenyl)ethylimidazole and prazosin
| Article | Year |
|---|---|
Peripheral cardiovascular alpha- and beta-adrenergic effects of some hypotensive and bradycardic arylalkyl imidazole derivatives in the rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Cardiovascular System; Clonidine; Decerebrate State; Dose-Response Relationship, Drug; Electric Stimulation; Female; Heart; Imidazoles; In Vitro Techniques; Male; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Yohimbine | 1985 |
The cardiovascular effects of MPV 295 [4(5)-2-(2,6-dimethylphenyl)ethylimidazole], a new antihypertensive agent with alpha 2-adrenoceptor agonistic properties.
Topics: Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Blood Pressure; Brain; Cardiovascular System; Cats; Clonidine; Heart Rate; Imidazoles; Male; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1983 |